Inclusion completed

IDO Peptide Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients

Cancer type: Lung cancer

Phase: I

Principal Investigator: Svane Inge Marie

Country: DK

Keywords: Denmark, Herlev, indeolamine 2, 3 dioxygenase, IDO, lung cancer, peptide vaccine

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01219348?term=NCT01219348&rank=1